Connect with us

Technology

4D Printing In Healthcare Market size is set to grow by USD 110.057 thousand from 2024-2028, Increased demand for personalized or customized medical devices to boost the market growth, Technavio

Published

on

NEW YORK, July 31, 2024 /PRNewswire/ — The global 4D printing in healthcare market size is estimated to grow by USD 110.057 thousand from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 44.82% during the forecast period. Increased demand for personalized or customized medical devices is driving market growth, with a trend towards emerging technological advances and applications of 4D printing in medical devices. However, high initial setup cost of 4d printing facilities poses a challenge. Key market players include 3D Systems Corp., Dassault Systemes SE, Desktop Metal Inc., EnvisionTEC GmBH, EOS GmbH, MATERIALISE NV, Organovo Holdings Inc., Otto GmbH and Co. KG, Poietis, and Stratasys Ltd..

Get a detailed analysis on regions, market segments, customer landscape, and companies – Click for the snapshot of this report

Forecast period

2024-2028

Base Year

2023

Historic Data

2017 – 2021

Segment Covered

Application (Implants, Medical devices, and Simulating and training), Component (Software and services, Equipment, and Programmable materials), and Geography (North America, Europe, Asia, and Rest of World (ROW))

Region Covered

North America, Europe, Asia, and Rest of World (ROW)

Key companies profiled

3D Systems Corp., Dassault Systemes SE, Desktop Metal Inc., EnvisionTEC GmBH, EOS GmbH, MATERIALISE NV, Organovo Holdings Inc., Otto GmbH and Co. KG, Poietis, and Stratasys Ltd.

Key Market Trends Fueling Growth

The healthcare industry is witnessing significant advancements in 4D printing technology, which is revolutionizing the production of medical devices. These technological strides have led to increased printer production speed, enhancing the volume capabilities of 4D systems. The benefits of 4D printing extend beyond speed, as it also reduces material waste and capital equipment expenditure, and decreases reliance on milling centers. In the dental sector, 4D printing offers higher precision and efficiency than competitive systems. For instance, Stratasys Ltd.’s acquisition of Origin in 2021 for mass production of additive-manufactured products underscores the industry’s focus on this technology. Furthermore, ongoing R&D efforts aim to develop new combinations of 4D printing materials and improve existing ones, expanding its applications and reducing costs. Notable materials include UV Silicone 60A MG, a biocompatible, bio-inert, non-biodegradable liquid silicone rubber, and HT PCL MG, a biodegradable thermoplastic polyester. EnvisionTEC’s introduction of the affordable E-OrthoShape material for 3D printing orthodontic models is another example of innovation in this field. Advancements in imaging modalities enable the creation of customized anatomical models with greater precision, further fueling the growth of 4D printing in healthcare. These developments are expected to create significant opportunities for the global 4D printing in healthcare market during the forecast period. 

The healthcare market is experiencing significant trends in 4D printing technology, which goes beyond traditional 3D printing by adding the fourth dimension of time. This innovation is revolutionizing medical equipment, drugs, and medical devices. 4D biomaterials are transforming dental crowns, smart bridges, surgical templates, aligners, and orthodontic braces, offering customized solutions. Technological developments in 4D printing are impacting various industries, including healthcare. Medical implants, biocompatibility, and biomedical splints are benefiting from this technology. Heart constructs, drug delivery systems, and even organ transplants are under development. 3D Systems is leading the investment in this field, with smart, programmable materials set to disrupt conventional manufacturing methods. The healthcare services administration is exploring 4D printing for organ constructs to address organ shortages and organ rejection issues. The technology’s potential extends to smart materials for heart valves, stents, and other medical devices. The integration of 4D printing technology in middle-income countries is expected to boost the healthcare market. Stereolithography and Fusion Deposition Modeling are popular 4D printing methods, with software and services supporting the design process. The automotive production and aerospace engineering industries have already embraced 4D printing, and healthcare is poised to follow suit. 

Discover 360° analysis of this market. For complete information, schedule your consultation- Book Here!

Market Challenges

The 4D printing market in healthcare faces significant challenges due to high capital costs. Expensive equipment, such as high-end additive manufacturing printers, and outsourced print service contracts contribute to these costs. Additionally, proprietary raw materials sold by manufacturers at high profit margins and the need for trained personnel to ensure quality production add to the expenses. A clinical 4D printing lab requires ancillary staff for printing and the time taken to produce parts ranges from hours to days, limiting mass manufacturing viability. These factors hinder the widespread adoption of 4D printers, thereby impeding the growth of the global 4D printing in healthcare market.The healthcare market is exploring the potential of 4D printing, a technology that goes beyond traditional 3D printing by adding a fourth dimension of time and motion. This technology holds significant promise for various healthcare applications, particularly in orthodontics, where braces can be custom-made to adjust to a patient’s teeth as they grow. However, challenges exist in implementing this technology. Conventional manufacturing methods in industries like automotive production and aerospace engineering have vastly different requirements than healthcare. Smart, programmable materials are crucial for 4D printing in healthcare. These materials can change shape in response to specific conditions, such as body temperature or pH levels. Heart valves, stents, and organ constructs are potential applications, addressing issues like blood flow and organ transplants. Health Resources and Services Administration faces organ shortages, making 4D printed organ constructs a potential solution. However, challenges like organ rejection, biocompatibility, and reimbursement policies must be addressed. 3D Systems, a leading 3D printing company, is investing in 4D printing technology, focusing on biomedical splits, drug delivery, and implants. Stereolithography and Fusion Deposition Modeling are popular 3D printing techniques, but software and services for 4D printing are still in development. Surgical guides, medical research models, patient-specific implants, and artificial intelligence are other potential applications. Hospitals and clinics are exploring this technology, with Prismlab leading the way in 4D printing research.

For more insights on driver and challenges – Download a Sample Report

Segment Overview 

This 4D printing in healthcare market report extensively covers market segmentation by

Application 1.1 Implants1.2 Medical devices1.3 Simulating and trainingComponent 2.1 Software and services2.2 Equipment2.3 Programmable materialsGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Implants- Medical implants are artificial devices designed to replace or enhance biological structures for various medical conditions, including cardiovascular, orthopedic, neurological, and dental ailments. These implants can be made from materials like skin, bone, metal, plastic, or ceramic and can be permanent or temporary. Risks and complications include infection, surgical failure, and implant failure. The healthcare industry has seen significant advancements with the introduction of 4D printing technology, enabling stimuli-responsive 3D structures in medical implants. This technology allows implants to change shape between programmed configurations, reversibly. The rising prevalence of chronic diseases, particularly among the aging population, is driving the demand for medical implants, leading to the growth of the 4D printing in healthcare market. Additionally, the increasing trend of tooth loss, particularly in the US, with about 3 million people currently having dental implants and an annual growth of 500,000, will further fuel the market expansion.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017 – 2021) – Download a Sample Report

Research Analysis

The 4D printing market in healthcare is revolutionizing the industry by enabling the creation of medical equipment, drugs, and devices with unique, time-dependent functions. This technology goes beyond traditional 3D printing by incorporating the fourth dimension of time, making medical innovations more dynamic and responsive to specific patient needs. Technological developments in 4D printing have expanded its applications in healthcare, from medical devices like dental crowns, smart bridges, surgical templates, aligners, and orthodontic braces, to advanced areas such as drug delivery systems and tissue engineering. 4D biomaterials, programmable materials, and design services are at the forefront of this innovation. These materials can change shape, release drugs, or adapt to environmental conditions over time, offering significant advantages over conventional manufacturing methods. Beyond healthcare, industries like automotive production and aerospace engineering have also embraced 4D printing for their unique challenges. The potential for 4D printing in healthcare is vast, with investment continuing to fuel development activities in this exciting field. Heart valves, for example, could be designed to open and close in response to specific conditions, while smart stents could adjust to the unique needs of individual patients. The possibilities are endless, making 4D printing a game-changer in the healthcare sector.

Market Research Overview

The 4D printing market in healthcare is experiencing significant growth as this innovative technology offers new possibilities in medical equipment, drugs, and medical devices. Unlike traditional 3D printing, 4D printing uses smart, programmable materials that can change shape over time in response to external stimuli. This technology holds immense potential in healthcare, from dental crowns and orthodontic braces to surgical templates, aligners, and even heart constructs. Technological developments in 4D printing are driving innovation in medical research models, implants, and drug delivery systems. The technology’s potential applications extend beyond medical devices, with the possibility of creating smart bridges, organ constructs, and even organs for transplant. The healthcare market is investing heavily in 4D printing technology, with development activities focusing on biocompatibility, biomedical splits, and smart materials. The technology’s potential to address organ shortages and organ rejection is a significant draw, with healthcare services administration and hospitals and clinics showing strong interest. The 4D printing market is not limited to high-income countries; middle-income countries are also investing in this technology, driven by its potential to reduce costs and improve access to healthcare. Stereolithography and Fusion Deposition Modeling are common 4D printing techniques, while software and services are essential components of the 4D printing ecosystem. Reimbursement policies and artificial intelligence are also playing a role in the adoption of 4D printing technology, with the potential to revolutionize conventional manufacturing methods in industries such as automotive production and aerospace engineering. Prismlab and other companies are leading the way in 4D printing research and development.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

ApplicationImplantsMedical DevicesSimulating And TrainingComponentSoftware And ServicesEquipmentProgrammable MaterialsGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/4d-printing-in-healthcare-market-size-is-set-to-grow-by-usd-110-057-thousand-from-2024-2028–increased-demand-for-personalized-or-customized-medical-devices-to-boost-the-market-growth-technavio-302210050.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Rarecells Inc. Appoints Dr. Neil Kurtz to Board of Directors

Published

on

By

NEW YORK and PARIS, March 26, 2025 /PRNewswire/ — Rarecells Inc., a pioneering company in liquid biopsy technology, is pleased to announce the appointment of Dr. Neil Kurtz to its Board of Directors. Dr. Kurtz, a renowned healthcare entrepreneur and executive, brings over 40 years of experience in the pharmaceutical, contract research, post-acute care, and medical diagnostic sectors.

Dr. Kurtz has a distinguished career as a founder of several successful companies, including Medidata Systems and Worldwide Clinical Trials, which collectively generated over $8 billion in value for investors. He has served as CEO of both public and private companies and has held senior executive positions in top pharmaceutical and healthcare organizations. His leadership experience includes serving as President and CEO of Golden Living, one of the United States’ largest providers of diversified care.

“We are delighted to welcome Dr. Kurtz to our Board of Directors,” said Dr. Patrizia Paterlini, CEO of Rarecells Inc. “His extensive expertise in diagnostics, finance, and scientific research, along with his strategic insights, will be invaluable as we continue to develop and commercialize our innovative liquid biopsy technology for early cancer detection. His addition strengthens our commitment to assembling a board with significant expertise to guide our mission of delivering unparalleled, label-free access to intact circulating tumor cells and their CTC-DNA for downstream analysis. We are confident that Dr. Kurtz’s leadership will further enhance our efforts to bring cutting-edge solutions to the forefront of precision oncology.”

“I am honored to join the already exceptional Board of Directors at Rarecells,” said Dr. Kurtz. “I am aligned with the company’s belief that through its ISET technology it has the potential to revolutionize cancer diagnostics and personalized treatment, having a profound impact on the lives of millions of patients worldwide. I look forward to sharing the insights I have gained across my industry experience and contributing to Rarecells’ growth and success in this critical field, where the unmet need remains critical.”

Dr. Kurtz is the 5th member of Rarecells’ Board of Directors. The other members are Patrizia Paterlini MD, PhD, President, CEO & Founder of Rarecells;  Neil Gunn, PhD, former head of Roche Molecular Systems and Roche Sequencing, Christian Brechot MD, PhD, Senior Associate Dean for Research in Global Affairs and the Associate Vice-President for International Partnerships and Innovation at the University of South Florida, Tampa & President of the Global Virus Network; Thierry de Marignac, Former Partner at Banque Mirabaud & Cie & Leading Investor.

About Rarecells Inc.

Rarecells Inc. is a leading company in the development of innovative non-invasive tests for early cancer diagnosis based on a proprietary hypersensitive AI-based Circulating Tumor Cells (CTCs) and CTC-DNA detection. Founded in 2012, the firm is headquartered in New York with offices and laboratories in New York and Paris. For more information, visit www.rarecells.com

Contact: media@rarecells.com

Photo – https://mma.prnewswire.com/media/2650018/Neil_Kurtz.jpg
Logo – https://mma.prnewswire.com/media/2650016/Rarecells_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/rarecells-inc-appoints-dr-neil-kurtz-to-board-of-directors-302411877.html

SOURCE Rarecells, Inc.

Continue Reading

Technology

Metrasens Broadens Market Reach with iT1 Source Partnership

Published

on

By

NAPERVILLE, Ill., March 26, 2025 /PRNewswire/ — Metrasens, a leading provider of advanced detection systems for security and safety applications, today announced a strategic partnership with iT1 Source, LLC, a leader in IT solutions, technology, and security services. This collaboration brings together iT1’s expertise in technology integration and Metrasens’ innovative security solutions to address the evolving needs of organizations seeking robust protection against physical threats.

Through this partnership, iT1 Source will offer Metrasens’ industry-leading passive detection technology, Metrasens Ultra, providing organizations with advanced, efficient, and flexible screening solutions. Unlike other detection systems, Metrasens Ultra is the only multi-use solution specifically designed to detect small concealed weapons and contraband that can lead to violence, as well as hidden electronics that pose a risk of sensitive or secure data leaks.

“We’re thrilled to partner with Metrasens to deliver state-of-the-art security solutions that align with our commitment to innovation and customer success,” said Ian Dunnington, Vice President of Public Sector at iT1 Source. “This partnership enables us to address growing concerns around physical security by offering our clients a proven product from Metrasens that enhances safety and peace of mind.”

Simon Goodyear, Chief Executive Officer at Metrasens, added, “Our collaboration with iT1 Source allows us to bring our cutting-edge detection technology to a wider audience. iT1 Source has a great reputation, strong relationships, and a good coverage model in markets where Metrasens is a strong fit.  Together, we are creating safer environments with efficient, reliable, and easy to implement solutions.”

Metrasens’ technology stands out for its ease of use, portability, and adaptability across a wide range of applications, including government facilities, healthcare institutions, and critical infrastructure. The passive detection system ensures a non-intrusive experience while maintaining high security standards, making it an ideal solution for organizations looking to enhance their safety measures without compromising efficiency.

By joining forces, iT1 Source and Metrasens are committed to delivering cutting-edge security solutions that safeguard people and assets against emerging threats. Organizations can now confidently leverage this powerful combination of technology and expertise to reinforce their security infrastructure.

About Metrasens
Metrasens is the world’s leading provider of advanced magnetic detection technologies. With a technology center and manufacturing facility in the United Kingdom, a North American sales and customer service hub in Chicago and a global network of distributors, the company’s innovative products are designed to address deficiencies in conventional screening methods and make the world safer and more secure. Metrasens’ mission is to take cutting-edge science from the laboratory and use it to create revolutionary, award-winning products that meet the distinct and diverse security needs of its customers. Metrasens’ core technologies have a wide range of real-world applications, embodied by solutions that are easy to adopt and simple to use.

For more information, visit http://www.metrasens.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/metrasens-broadens-market-reach-with-it1-source-partnership-302411295.html

SOURCE Metrasens

Continue Reading

Technology

Orijin and Interplay Learning Expand Partnership to Offer 15 Learning Pathways to Support Pre-Apprenticeships and Additional Skilled Trades Training in Correctional Facilities

Published

on

By

AUSTIN, Texas and NEW YORK, March 26, 2025 /PRNewswire/ — Orijin, a technology leader in evidence-based learning and workforce development programming for correctional jurisdictions, and Interplay Learning, the leading provider of immersive skilled trades training, have expanded their partnership to provide greater access to workforce development opportunities for justice-impacted individuals. This expansion introduces pre-apprenticeship pathways and additional skilled trades training options to better prepare individuals for sustainable careers post-release.

Building on the success of their initial partnership, which provided Interplay’s career exploration and foundational training through Orijin’s secure platform, this new phase extends the offering to include 15 comprehensive learning pathways from Interplay Learning. These learning tracks feature expanded course hours and industry-relevant training, enabling learners to develop in-demand trade skills in fields such as HVAC, electrical, plumbing, and facilities maintenance.

Delivered on safe and secure digital tablets, these expanded pathways include options for pre-apprenticeship opportunities, designed to help individuals transition more seamlessly into the workforce. These structured programs provide hands-on skills training that aligns with industry expectations, increasing employability and reducing barriers to job placement post-incarceration.

“This partnership expansion represents a significant step in breaking down employment barriers for justice-impacted individuals,” said Arti Finn, Chief Strategy Officer and Co-Founder at Orijin. “By integrating pre-apprenticeships and deeper training opportunities, we are not only providing education but also real pathways to sustainable careers that lead to long-term success.”

Orijin’s secure managed learning platform ensures that learners in correctional facilities can access Interplay Learning’s hands-on training in a controlled environment. The expanded training catalog complements Orijin’s existing educational content, which includes employability readiness, ESL courses, and financial literacy, providing a holistic approach to re-entry preparation.

“Through our partnership with Orijin, we are making high-quality skills training more accessible to justice-involved individuals who are eager to build stable careers,” said Doug Donovan, CEO of Interplay Learning. “By expanding our learning pathways and introducing pre-apprenticeships, we’re equipping more individuals with the tools they need to successfully re-enter the workforce.”

Orijin and Interplay Learning remain committed to fostering career readiness among justice-involved individuals, helping them gain the skills and confidence needed to secure meaningful employment upon release. 

About Interplay Learning
Interplay Learning, the leader in immersive learning for the skilled trades, now includes Industrial Training International (ITI), the global leader in specialized industrial learning solutions. Leveraging instructor-led training, online simulations, AI, and VR, Interplay helps organizations and educational institutions upskill faster, reduce risk, and increase operational readiness. With nearly 600,000 people trained, Interplay is shaping the future of workforce development, building better careers and better lives. Visit www.interplaylearning.com to learn more.

About Orijin
Founded in 2014, Orijin breaks the cycle of incarceration by preparing every justice-impacted individual for a sustainable career. Orijin provides a robust, cloud-based learning and communications platform delivered on secure devices in hundreds of correctional facilities across the country. As a public benefit corporation and Certified B Corporation, Orijin does not charge incarcerated individuals nor their families for its solutions. For more information, visit www.orijin.works.

MEDIA CONTACT: 
Heather Ripley
Ripley PR
(865) 977-1973
hripley@ripleypr.com

View original content:https://www.prnewswire.com/news-releases/orijin-and-interplay-learning-expand-partnership-to-offer-15-learning-pathways-to-support-pre-apprenticeships-and-additional-skilled-trades-training-in-correctional-facilities-302411401.html

SOURCE Interplay Learning

Continue Reading

Trending